Treatment for osteoporosis with bisphosphonates and atypical femur fractures

Treatment with bisphosphonates (Alendronate, Risedronate, etc.) has been linked in some studies with the appearance of fractures in the femur of atypical features. This fact has raised concern in patients and doctors. An interesting article published this month in the prestigious medical journal New England Journal of Medicine teaches us that although this type of fractures may appear in patients treated with bisphosphonates, their appearance is very rare and the benefits obtained in the prevention of fractures with These drugs are far superior to the possible risk of suffering this undesirable effect. (n engl j med 364; May 18, 2011)

Recommended Posts

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *